suliqua
sanofi winthrop industrie - insulin glargine, lixisenatide - diabetes mellitus, type 2 - narkotika anvendt i diabetes - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
alminox "dak" 500 mg + 100 mg tyggetabletter
orifarm healthcare a/s - aluminiumaminoacetat, hydrat, magnesiumhydroxid, tungt - tyggetabletter - 500 mg + 100 mg
antabus 200 mg brusetabletter
teva b.v. - disulfiram - brusetabletter - 200 mg
antabus 400 mg brusetabletter
2care4 aps - disulfiram - brusetabletter - 400 mg
antabus 400 mg brusetabletter
europharma.dk aps - disulfiram - brusetabletter - 400 mg
antabus 400 mg brusetabletter
orifarm a/s - disulfiram - brusetabletter - 400 mg
antabus 400 mg brusetabletter
abacus medicine a/s - disulfiram - brusetabletter - 400 mg
apozepam 2 mg tabletter
teva b.v. - diazepam - tabletter - 2 mg
apozepam 5 mg tabletter
teva b.v. - diazepam - tabletter - 5 mg
bcg "medac" pulver og solvens til intravesikal suspension
medac, gesellschaft für klinische spezialpräparate mbh - bacillus calmette guerin (bcg) stamme rivm deriveret fra stamme 1173-p2, frysetørret (levende) - pulver og solvens til intravesikal suspension